Clinical Trial Update: CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer [NA]

View source ↗

Summary

An ongoing clinical trial is evaluating CytoREductive prostAtectomy for poly-metastatic, hormone-sensitive prostate cancer; the study is currently recruiting at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: RenJi Hospital | Conditions: Prostate Cancer | NA | Status: RECRUITING